Filament Health, a Vancouver-based company, is pioneering a breakthrough medical-grade ayahuasca pill. This pill could potentially provide individuals with an authentic ayahuasca experience without the need to travel to South America or disrupt their daily lives.

The coming is working to obtain FDA authorization to initiate its Phase 1 clinical trial for its ayahuasca pill, which is expected to take place in the first half of 2023.

Psychedelic Spotlight has a detailed look at the pill and the company.

Ayahuasca has been used for centuries in Central and South America as a sacrament in ceremonies due to its powerful healing and visionary effects. It has recently gained traction amongst the rich and famous, and research has demonstrated its potential therapeutic effects for a variety of mental and physical illnesses. With the manufacturing process for standardized ayahuasca just beginning, it is an opportune time to explore this topic.

By Kenny Hofmann

Kenny is a staff writer and avid psychedelics explorer.

Leave a Reply

Your email address will not be published. Required fields are marked *